KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Other financing activities (2016 - 2025)

Historic Other financing activities for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $2.0 million.

  • Bausch Health Companies' Other financing activities rose 11538.46% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.0 million, marking a year-over-year increase of 50000.0%. This contributed to the annual value of -$11.0 million for FY2024, which is 13055.56% down from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Other financing activities is $2.0 million, which was up 11538.46% from $31.0 million recorded in Q2 2025.
  • Bausch Health Companies' 5-year Other financing activities high stood at $37.0 million for Q3 2022, and its period low was -$13.0 million during Q3 2024.
  • Its 5-year average for Other financing activities is $13.0 million, with a median of $7.5 million in 2021.
  • The largest annual percentage gain for Bausch Health Companies' Other financing activities in the last 5 years was 30000.0% (2024), contrasted with its biggest fall of 13714.29% (2024).
  • Quarter analysis of 5 years shows Bausch Health Companies' Other financing activities stood at $10.0 million in 2021, then soared by 270.0% to $37.0 million in 2022, then fell by 5.41% to $35.0 million in 2023, then plummeted by 105.71% to -$2.0 million in 2024, then soared by 200.0% to $2.0 million in 2025.
  • Its Other financing activities stands at $2.0 million for Q3 2025, versus $31.0 million for Q2 2025 and $5.0 million for Q1 2025.